Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gain Therapeutics (GANX) Interest & Investment Income (2024 - 2025)

Historic Interest & Investment Income for Gain Therapeutics (GANX) over the last 2 years, with Q3 2025 value amounting to $78074.0.

  • Gain Therapeutics' Interest & Investment Income fell 2592.95% to $78074.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $212912.0, marking a year-over-year change of. This contributed to the annual value of $357096.0 for FY2024, which is 2774.76% down from last year.
  • Gain Therapeutics' Interest & Investment Income amounted to $78074.0 in Q3 2025, which was down 2592.95% from $42568.0 recorded in Q2 2025.
  • Gain Therapeutics' 5-year Interest & Investment Income high stood at $115303.0 for Q1 2024, and its period low was $40413.0 during Q1 2025.